The Self-Administered Psoriasis Area and Severity Index provides an objective measure of psoriasis severity [11]

British Journal of Dermatology

Volumn 152, Issue 2, 2005, Pages 382-383

  Feldman, S R ^a   Clark, A R ^a   Venkat, A P ^a   Fleischer Jr , A B ^a   Anderson, R T ^a   Rajagopalan, R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ERYTHEMA; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS VULGARIS; QUALITY OF LIFE; RATING SCALE; SKIN DEFECT; SKIN INDURATION; VISUAL ANALOG SCALE;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SELF CARE; SEVERITY OF ILLNESS INDEX;

EID: 14844293059     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06351.x     Document Type: Letter

References (5)

1. Fleischer AB, Feldman SR, Dekle CL. The SAPASI is valid and responsive to psoriasis disease severity changes in a multi-center clinical trial. J Dermatol 1999; 26:210-15.
2. Anderson R, Rajagopalan R. Responsiveness of the Dermatology-Specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled trial. Qual Life Res 1998; 7:723-34.
3. Sampogna F, Sera F, Mazzotti E et al. Performance of the Self-Administered Psoriasis Area and Severity Index in evaluating clinical and sociodemographic subgroups of patients with psoriasis. Arch Dermatol 2003; 139:353-8.
4. Kirby B, Richards HL, Woo P et al. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45:72-6.
5. Gottlieb AB, Chaudhari U, Baker DG et al. The National Psoriasis Foundation Psoriasis Score (NPF-PS) system versus the Psoriasis Area Severity Index (PASI) and Physician's Global Assessment (PGA): a comparison. J Drugs Dermatol 2003; 2:260-6.